Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, CME Group Inc (NASDAQ: CME) closed at $197.25 down -0.10% from its previous closing price of $197.44. In other words, the price has decreased by -$0.10 from its previous closing price. On the day, 2.5 million shares were traded. CME stock price reached its highest trading level at $200.545 during the session, while it also had its lowest trading level at $194.93.
Ratios:
For a deeper understanding of CME Group Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 45.44 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 21.12. In the meantime, Its Debt-to-Equity ratio is 0.14 whereas as Long-Term Debt/Eq ratio is at 0.11.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, JP Morgan on June 21, 2024, Downgraded its rating to Underweight and sets its target price to $187 from $206 previously.
On January 08, 2024, Barclays Downgraded its rating to Equal Weight which previously was Overweight and also lowered its target price recommendation from $244 to $222.
Goldman Downgraded its Neutral to Sell on January 03, 2024, while the target price for the stock was maintained at $195.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 25 ’24 when SHEPARD WILLIAM R bought 312 shares for $195.07 per share. The transaction valued at 60,885 led to the insider holds 253,655 shares of the business.
SHEPARD WILLIAM R bought 14 shares of CME for $2,684 on Jun 25 ’24. The Director now owns 2,348 shares after completing the transaction at $195.07 per share. On Jun 13 ’24, another insider, Carey Charles P, who serves as the Director of the company, sold 3,000 shares for $195.44 each. As a result, the insider received 586,320 and left with 7,163 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CME now has a Market Capitalization of 71022821376 and an Enterprise Value of 73405710336. As of this moment, CME’s Price-to-Earnings (P/E) ratio for their current fiscal year is 22.47, and their Forward P/E ratio for the next fiscal year is 19.78. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 9.44. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.63 while its Price-to-Book (P/B) ratio in mrq is 2.61. Its current Enterprise Value per Revenue stands at 13.072 whereas that against EBITDA is 19.05.
Stock Price History:
The Beta on a monthly basis for CME is 0.53, which has changed by -0.0070975423 over the last 52 weeks, in comparison to a change of 0.19608545 over the same period for the S&P500. Over the past 52 weeks, CME has reached a high of $222.63, while it has fallen to a 52-week low of $183.76. The 50-Day Moving Average of the stock is -1.88%, while the 200-Day Moving Average is calculated to be -4.99%.
Shares Statistics:
For the past three months, CME has traded an average of 2.19M shares per day and 2327410 over the past ten days. A total of 359.23M shares are outstanding, with a floating share count of 358.87M. Insiders hold about 0.33% of the company’s shares, while institutions hold 89.47% stake in the company. Shares short for CME as of 1719532800 were 4506882 with a Short Ratio of 2.06, compared to 1717113600 on 5075339. Therefore, it implies a Short% of Shares Outstanding of 4506882 and a Short% of Float of 1.26.
Dividends & Splits
The stock’s 5-year Average Dividend Yield is 3.1. The current Payout Ratio is 108.90% for CME, which recently paid a dividend on 2024-06-07 with an ex-dividend date of 1717718400. Stock splits for the company last occurred on 2012-07-23 when the company split stock in a 5:1 ratio.
